Research statistics
CJC-1295 research: publications and trials
At a glance
Publications, all years
27
Since 2005
Publications in 2026 so far
6
Through November 15, 2026
Human clinical research
11.1%
3 of 27 classified
Registered clinical trials
1
ClinicalTrials.gov
Randomized controlled trials
1
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
59.3%
7 animal · 9 in vitro · 0 computational
Records that only mention it
8
Not counted above
Status in the library: Research only. Groups: Growth hormone axis.
What to keep in mind
- Fewer than three randomized controlled trials are indexed.
Publications by year
CJC-1295 publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 2005 | 1 | 1 | 0 | 0 | 2 |
| 2006 | 1 | 1 | 0 | 0 | 2 |
| 2009 | 1 | 1 | 0 | 0 | 2 |
| 2010 | 0 | 1 | 0 | 0 | 1 |
| 2011 | 0 | 0 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 0 | 0 | 1 |
| 2015 | 0 | 1 | 0 | 0 | 1 |
| 2016 | 0 | 1 | 1 | 0 | 2 |
| 2018 | 0 | 1 | 0 | 0 | 1 |
| 2019 | 0 | 1 | 0 | 0 | 1 |
| 2020 | 0 | 1 | 0 | 0 | 1 |
| 2021 | 0 | 1 | 0 | 0 | 1 |
| 2022 | 0 | 2 | 0 | 0 | 2 |
| 2023 | 0 | 1 | 0 | 0 | 1 |
| 2024 | 0 | 1 | 0 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 1 | 1 |
| 2026 (to date) | 0 | 1 | 5 | 0 | 6 |
Study types
| In vitro study | 9 |
|---|---|
| Animal study | 7 |
| Review | 7 |
| Other clinical trial | 2 |
| Editorial, letter or other | 1 |
| Randomized controlled trial | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Endocrinology | 10 |
|---|---|
| Metabolic health | 5 |
| Longevity and aging | 4 |
| Tissue repair | 4 |
| Musculoskeletal | 3 |
| Neurological and mental health | 3 |
| Cardiovascular | 1 |
| Dermatology | 1 |
| Immune system | 1 |
| Obesity and weight management | 1 |
| Reproductive and sexual health | 1 |
Registered clinical trials
A registration is not a result.
Terminated: 1
Phase 2: 1
| Trial | Status | Phase | Started | Results |
|---|---|---|---|---|
| A Study to Evaluate CJC 1295 in HIV Patients With Visceral ObesityNCT00267527 · 120 enrolled | Terminated | Phase 2 | 2005-12 | — |
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
The Journal of clinical endocrinology and metabolism · December 13, 2005 · Randomized controlled trial · cited 48 times
PMID 16352683 · DOI 10.1210/jc.2005-1536 · Human clinical research
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · April 21, 2009 · Other clinical trial · cited 28 times · open access
PMID 19386527 · DOI 10.1016/j.ghir.2009.03.001 · Human clinical research
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
The Journal of clinical endocrinology and metabolism · October 3, 2006 · Other clinical trial · cited 36 times
PMID 17018654 · DOI 10.1210/jc.2006-1702 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.
Methods (San Diego, Calif.) · August 18, 2011 · Review · cited 99 times
PMID 21871962 · DOI 10.1016/j.ymeth.2011.08.009 · Reviews and meta-analyses
- Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.
Drug testing and analysis · November 1, 2010 · In vitro study · cited 59 times
PMID 21204297 · DOI 10.1002/dta.233 · In vitro studies
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
The Journal of clinical endocrinology and metabolism · December 13, 2005 · Randomized controlled trial · cited 48 times
PMID 16352683 · DOI 10.1210/jc.2005-1536 · Human clinical research
- Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.
Analytical and bioanalytical chemistry · February 15, 2016 · In vitro study · cited 43 times · open access
PMID 26879649 · DOI 10.1007/s00216-016-9377-3 · In vitro studies
- Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.
Substance use & misuse · January 15, 2016 · Review · cited 41 times · open access
PMID 26771670 · DOI 10.3109/10826084.2015.1082595 · Reviews and meta-analyses
Latest publications
- Detection of CJC-1295 in Equine Plasma by ELISA.
Drug testing and analysis · October 14, 2026 · Animal study · cited 0 times · open access
PMID 42876013 · DOI 10.1002/dta.70171 · Animal studies
- Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
The American journal of sports medicine · August 11, 2026 · Review · cited 1 times · open access
PMID 42578445 · DOI 10.1177/03635465261464420 · Reviews and meta-analyses
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access
PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Sports medicine (Auckland, N.Z.) · April 12, 2026 · Review · cited 8 times · open access
PMID 41966639 · DOI 10.1007/s40279-026-02437-0 · Reviews and meta-analyses
- Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Frontiers in aging · April 7, 2026 · Review · cited 4 times · open access
PMID 42021992 · DOI 10.3389/fragi.2026.1790247 · Reviews and meta-analyses
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
The American journal of sports medicine · January 1, 2026 · Review · cited 12 times
PMID 41476424 · DOI 10.1177/03635465251357593 · Reviews and meta-analyses
- Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.
Journal of pharmaceutical and biomedical analysis · October 20, 2025 · Editorial, letter or other · cited 1 times
PMID 41138283 · DOI 10.1016/j.jpba.2025.117207 · Commentary and other
- Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.
Journal of mass spectrometry : JMS · January 1, 2024 · In vitro study · cited 5 times · open access
PMID 38197510 · DOI 10.1002/jms.4996 · In vitro studies
- Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.
Analytical biochemistry · October 6, 2023 · In vitro study · cited 4 times
PMID 37806509 · DOI 10.1016/j.ab.2023.115336 · In vitro studies
- Probing for peptidic drugs (2-10 kDa) in doping control blood samples.
Analytical science advances · August 22, 2022 · In vitro study · cited 9 times · open access
PMID 38716080 · DOI 10.1002/ansa.202200027 · In vitro studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: CJC-1295; cjc-1295-dac; CJC-1295 with DAC; DAC:GRF; Modified GRF with DAC
((TITLE_ABS:"CJC-1295" OR CHEM:"CJC-1295" OR TITLE_ABS:"CJC1295" OR CHEM:"CJC1295") OR (TITLE_ABS:"cjc-1295-dac" OR CHEM:"cjc-1295-dac" OR TITLE_ABS:"cjc1295-dac" OR CHEM:"cjc1295-dac") OR (TITLE_ABS:"CJC-1295 with DAC" OR CHEM:"CJC-1295 with DAC" OR TITLE_ABS:"CJC1295 with DAC" OR CHEM:"CJC1295 with DAC") OR (TITLE_ABS:"DAC:GRF" OR CHEM:"DAC:GRF") OR (TITLE_ABS:"Modified GRF with DAC" OR CHEM:"Modified GRF with DAC")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). CJC-1295 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/cjc-1295